Home LiteratureArticle Details
PMID: 3490520 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.

The Journal of infectious diseases ·Vol. 154 ·No. 5 ·1986-11-00 ·Pages 792-800

Sanders CC, Sanders WE

Abstract

The interaction of type I beta-lactamases with diverse beta-lactam compounds representing cephalosporins, cephamycins, penicillins, penams, penems, carbapenems, monobactams, and clavams was examined by using various Enterobacteriaceae and Pseudomonas aeruginosa as sources of the enzymes. The ability of a given drug to reversibly induce beta-lactamase was unrelated to its ability to select mutants stably derepressed for beta-lactamase production. Imipenem was one of the most-potent enzyme inducers, yet it did not select derepressed mutants. Many of the newer cephalosporins were poor enzyme inducers but readily selected derepressed mutants. Resistance to hydrolysis did not predict a drug's inhibitory activity against derepressed mutants. The activity of the penems, penams, and carbapenems was least affected by derepression of beta-lactamase, whereas the activity of anionic cephalosporins and aztreonam was most affected.

MeSH Terms
Anti-Bacterial Agents/metabolism Gram-Negative Bacteria/enzymology Hydrolysis Microbial Sensitivity Tests Mutation beta-Lactamases/metabolism beta-Lactams
Chemicals
Anti-Bacterial Agents beta-Lactams beta-Lactamases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Sanders C C
Sanders W E
Article Info
Journal
The Journal of infectious diseases
Abbr.
J Infect Dis
ISSN
0022-1899
Published
1986-11-00
Pages
792-800
Language
English
Region
United States
NLM ID
0413675
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com